• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Prenetics Global Limited - Class A Ordinary Share (NQ:PRE)

    19.99 -0.97 (-4.63%)
    Delayed Quote Updated: 12:03 PM EDT, Oct 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 132,096
    Open 21.17
    Bid (Size) 19.95 (4,900)
    Ask (Size) 20.14 (100)
    Prev. Close 20.96
    Today's Range 19.81 - 21.17
    52wk Range 11.37 - 27.24
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics (PRE) Q2 2026 Earnings Call Transcript ↗
    IM8 brand hits $251M annualized run rate as adjusted free cash flow turns positive. 
    Via The Motley Fool
    Topics Earnings

    Performance

    52-Week Range 26.6% below 52-week high
    19.99
    11.3752W Low 27.2452W High
    1 Week 15.3% below 1-week high
    19.851W Low 23.601W High

    Prenetics Global Limited - Class A Ordinary Share (PRE) traded between $11.37 and $27.24 over the past 52 weeks and last traded at $19.99, 26.6% below its 52-week high. Over the past week it ranged between $19.85 and $23.60.

    Past 12 Months
    -12.5%
    -22.0%
    +14.3%
    +0.2%
    +26.7%
    +33.4%
    1W -$2.85
    1M -$5.63
    3M +$2.50
    6M +$0.03
    YTD +$4.21
    1Y +$5.01

    PRE was +33.4% over the past year, +0.2% over six months, +26.7% year to date, -12.5% in the last week.

    12 Months vs Market
    PRE
    +33.4%
    DIA
    +10.4%
    SPY
    +16.3%
    QQQ
    +25.4%
    IWM
    +14.5%

    Over the past 12 months PRE returned +33.4% versus DIA (Dow) +10.4%, SPY (S&P 500) +16.3%, QQQ (Nasdaq 100) +25.4% and IWM (Russell 2000) +14.5%.

    Volume & Liquidity 0.58× 3-mo avg
    Today 132,096 3-mo avg 228.7K
    1W
    138.1K
    1M
    174.5K
    3M
    228.7K
    6M
    218.7K
    YTD
    231.7K
    1Y
    212.5K

    PRE most recently traded 132,096 shares against a 3-month average daily volume of 228.7K.

    More News

    Read More
    News headline image
    Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Global Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics (PRE) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Prenetics Global Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics to Participate in the 38th Annual ROTH Conference
    From Prenetics Global Limited
    Via GlobeNewswire
    The market is filled with gapping stocks in Friday's session. ↗
    Via Chartmill
    News headline image
    Prenetics Authorizes $40 Million Share Repurchase Program
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
    From Prenetics Global Limited
    Via GlobeNewswire

    Frequently Asked Questions

    Is Prenetics Global Limited - Class A Ordinary Share publicly traded?
    Yes, Prenetics Global Limited - Class A Ordinary Share is publicly traded.
    What exchange does Prenetics Global Limited - Class A Ordinary Share trade on?
    Prenetics Global Limited - Class A Ordinary Share trades on the Nasdaq Stock Market
    What is the ticker symbol for Prenetics Global Limited - Class A Ordinary Share?
    The ticker symbol for Prenetics Global Limited - Class A Ordinary Share is PRE on the Nasdaq Stock Market
    What is the current price of Prenetics Global Limited - Class A Ordinary Share?
    The current price of Prenetics Global Limited - Class A Ordinary Share is 19.99
    When was Prenetics Global Limited - Class A Ordinary Share last traded?
    The last trade of Prenetics Global Limited - Class A Ordinary Share was at 10/06/26 12:03 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.